OTC · NUGS
Cannabis Strategic Ventures
$0.00-$0.00 (-16.67%)
Cannabis Strategic Ventures’s quoted price sits in the lower half of its reported 52-week range, 95.55% below the high.
Loading market information…
OTC · HCANF · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Halo Collective Inc.’s next earnings report is currently expected on Nov 17, 2026, with estimated earnings per share of -$103.72. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Halo Collective Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Founded in 2016 and headquartered in Toronto, Canada, Halo Collective Inc. is a vertically integrated cannabis company. (The firm adopted its current name in January 2021, previously operating as Halo Labs Inc.) Its core operations involve cultivating, manufacturing, and distributing cannabis products throughout the United States. The company specializes in growing, extracting, and processing various forms of cannabis, including flowers, oils, and concentrates. Beyond these, Halo Collective also offers a range of edible products, such as cannabis-infused gummies and a distinctive syrup beverage, available in California and Oregon. Halo Collective markets both its own branded products—like Hush, Mojave, and Exhale—and private label items, primarily selling its cannabis offerings to dispensaries. Its clientele includes licensed retailers and wholesalers. The company also maintains significant collaborations, including a strategic partnership with High Tide Inc. and an alliance with OG DNA Genetics Inc. focused on developing cannabis genetics in Oregon.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00-$0.00 (-16.67%)
Cannabis Strategic Ventures’s quoted price sits in the lower half of its reported 52-week range, 95.55% below the high.
$0.00$0.00 (0.0%)
North American Cannabis Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
DrazCanna, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Founders Bay Holdings’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Aeolus Pharmaceuticals, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
VioQuest Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
MPX International Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Sentry Petroleum Ltd: Healthcare · Drug Manufacturers - Specialty & Generic.
